Clinical Trial: A randomized, open-labeled, parallel-controlled, multi-center and non-inferiority clinical study for evaluation of the effectiveness and safety of Bausch + Lomb (samfilcon A) soft (hydrophilic) contact lens for astigmatism in terms of correcting ametropia (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, open-labeled, parallel-controlled, multi-center and non-inferiority clinical study for evaluation of the effectiveness and safety of Bausch + Lomb (samfilcon A) soft (hydrophilic) contact lens for astigmatism in terms of correcting ametropia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131656

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: Eye&Ent Hospital of Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=262815

Published by HT Digital Content Services with permission from Health Daily Diges...